Dyslipidemia is a medical condition marked by an abnormal lipid profile, encompassing cholesterol and triglycerides in the bloodstream. Its significance lies in its association with the development of cardiovascular diseases, notably atherosclerosis and coronary artery disease. This condition arises from disruptions in lipid production, utilization, or clearance, resulting in elevated levels of LDL cholesterol, often termed "bad" cholesterol, and decreased levels of HDL cholesterol, referred to as "good" cholesterol. Contributing factors to dyslipidemia include a combination of genetic predisposition, lifestyle choices, and underlying health conditions. Unhealthy dietary patterns, sedentary lifestyle, and obesity play substantial roles in its onset.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : TED2HOME - A low cost automatic external defibrillator for home/office
Abraham Teddy Weiss, Hadassah University Hospital, Israel
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain